Method for promoting osteogenic differentiation of bone marrow mesenchymal stem cells
A bone marrow mesenchymal and osteogenic differentiation technology, applied in the field of stem cells, can solve the problems of low induction differentiation efficiency, long time, and inconvenient clinical application, and achieve the effect of shortening the time of osteogenic differentiation and improving efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] A method for promoting osteogenic differentiation of bone marrow mesenchymal stem cells, comprising the following steps:
[0021] (1) Human bone marrow mesenchymal stem cells were inoculated in the basal medium DMEM / F12 in a 12-well culture plate at a seeding density of 1×10 4 cells / mL, at 37°C, 5% CO 2 cultured in an incubator, and when the cell confluency reached 80%, it was digested and subcultured with 0.25% trypsin, and the ratio of subculture was 1:3;
[0022] (2) Inoculate the third-generation bone marrow mesenchymal stem cells obtained from the subculture in the above step (1) on the differentiation medium of a 6-well culture plate, at 37°C, 5% CO 2 Induced differentiation in an incubator with a seeding density of 2×10 5 cells / mL, change the solution every other day;
[0023] The above differentiation medium includes DMEM / F12 medium, insulin 20 μg / mL, dexamethasone 8 ng / mL, ascorbic acid 45 μg / mL, sulfobutyl-β-cyclodextrin 20 μg / mL, betaine 50 μg / mL, indium a...
Embodiment 2
[0025] A method for promoting osteogenic differentiation of bone marrow mesenchymal stem cells, comprising the following steps:
[0026] (1) Human bone marrow mesenchymal stem cells were inoculated in the basal medium DMEM / F12 in a 12-well culture plate at a seeding density of 1.5×10 4 cells / mL, at 37°C, 5% CO 2 cultured in an incubator, and when the cell confluency reached 85%, it was digested and subcultured with 0.25% trypsin, and the subculture ratio was 1:4;
[0027] (2) Inoculate the fourth-generation bone marrow mesenchymal stem cells obtained from the subculture in the above step (1) on the differentiation medium of a 6-well culture plate, and inoculate at 37°C, 5% CO 2 Induced differentiation in an incubator with a seeding density of 3×10 5 cells / mL, change the solution every other day;
[0028] The above differentiation medium includes DMEM / F12 medium, insulin 18 μg / mL, dexamethasone 5 ng / mL, ascorbic acid 40 μg / mL, sulfobutyl-β-cyclodextrin 15 μg / mL, betaine 45 μ...
Embodiment 3
[0030] A method for promoting osteogenic differentiation of bone marrow mesenchymal stem cells, comprising the following steps:
[0031] (1) Human bone marrow mesenchymal stem cells were inoculated in the basal medium DMEM / F12 in a 12-well culture plate at a seeding density of 2×10 4 cells / mL, at 37°C, 5% CO 2 cultured in an incubator, and when the cell confluency reached 90%, it was digested and subcultured with 0.25% trypsin, and the subculture ratio was 1:4;
[0032] (2) Inoculate the fifth-generation bone marrow mesenchymal stem cells obtained from the subculture in the above step (1) on the differentiation medium of a 6-well culture plate, and inoculate at 37°C, 5% CO 2 Differentiation was induced in an incubator with a seeding density of 4×10 5 cells / mL, change the solution every other day;
[0033] The above differentiation medium includes DMEM / F12 medium, insulin 22 μg / mL, dexamethasone 10 ng / mL, ascorbic acid 50 μg / mL, sulfobutyl-β-cyclodextrin 23 μg / mL, betaine 52...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com